• Biotinylated Cynomolgus CD3E&CD3D on Tris-Bis PAGE under reduced conditions. The purity is greater than 95%.
  • The purity of Biotinylated Cynomolgus CD3E&CD3D was greater than 95% as determined by SEC-HPLC.
  • Immobilized Anti-CD3, hFc Tag Antibody at 5 Mu g/ml (100 Mu l/well) on the plate. Dose response curve for Biotinylated Cynomolgus CD3E&CD3D, hFc Tag with the EC50 of 58. 2ng/ml determined by ELISA.

Cynomolgus CD3E&CD3D/CD3 epsilon&CD3 delta protein (Recombinant) (C-hFc) {Biotin} (STJP001559)

SKU:
STJP001559

Shipping:
Free Shipping
Current Stock:
Host: HEK293
Note: STRICTLY FOR FURTHER RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Recombinant-Cynomolgus CD3E&CD3D/CD3 epsilon&CD3 delta-C-hFc protein was developed from hek293 and has a target region of C-hFc. For use in research applications.
Conjugation: Biotin
Formulation: Lyophilised from 0.2 µm filtered PBS solution pH7.4.
Dilution Range: Upon receipt centrifuge vial to ensure maximal product extraction, recommended: 20sec, 5K RPM
Storage Instruction: The lyophilized protein is stable for at least 1 year from date of receipt at-20°C.
Endotoxin: Endotoxin content was assayed using a LAL gel clot method. Endotoxin level was found to be less than 0.1 ng/µg (1EU/µg).
Immunogen Region: Gln22-Asp117 (CD3E) & Phe22-Ala105 (CD3D)
Immunogen: DNA sequence encoding Cynomolgus CD3E&CD3D/CD3 epsilon&CD3 delta (Primary Amine Labeling) including a C-hFc tag was expressed in HEK293 Cells. The recombinant protein was then biotinylated site specific using the AVItag biotinylation technology.
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance